FDA grants Jacobus Pharma approval for rare disease drug
(Reuters) – Jacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton…
UK’s Vectura wins patent infringement case against GlaxoSmithKline in U.S
(Reuters) – British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
Trump says he is holding big Pharma accountable in opioid fight
ATLANTA (Reuters) – U.S. President Donald Trump touted progress in the fight against opioid abuse on Wednesday and promised to…
Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey,…
U.S. measles cases surge nearly 20 percent in early April, CDC says
(Reuters) – The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent…
Catalent seeks slice of gene therapy market with Paragon buy
(Reuters) – Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion…
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals…
Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease…
Jazz Pharma’s sleep disorder treatment gets FDA nod
(Reuters) – The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep…
Amarin’s Vascepa cuts occurrence of serious heart problems 30 percent: study
(Reuters) – A high dose of Amarin Corp’s Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart…
FDA approves generic valsartan amid drug shortage
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2,…
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant…
FDA chief tough on e-cigs steps down in surprise resignation
WASHINGTON (Reuters) – U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down…
Eli Lilly seeks to quell drug price anger with cheaper insulin
(Reuters) – Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog,…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled…
Venezuela crisis could spark surge in infectious diseases: study
FILE PHOTO: A Venezuelan health worker fumigates the Valle slum to help control the spread of the mosquito-borne Zika virus…
Insys founder ran bribe scheme to push opioid: U.S. prosecutor
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive…
Italy drugmaker Zambon ready to splash out in U.S., China push
MILAN (Reuters) – Italian drugmaker Zambon is looking to China and the U.S. to grow its respiratory and nervous system…
J&J, U.S. states settle hip implant claims for $120 million
(Reuters) – Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing…
U.S. FDA approves Alexion Pharma’s blood disorder drug
(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s…
FDA panel backs prescribing opioid overdose reversal drug along with painkillers
(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal…
Johnson & Johnson’s multiple myeloma drug reduces risk of death in late-stage study
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake (Reuters) –…
JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial
FILE PHOTO: The Johnson and Johnson logo is seen at an office building in Singapore January 17, 2018. REUTERS/Thomas White…
BioMarin sets stage early for hemophilia cure off-Broadway
(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six…
Many U.S. drugstores fail to provide naloxone for opioid overdoses
(Reuters Health) – Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest…
EMA committee recommends restrictions on fluoroquinolone, quinolone antibiotics
(Reuters) – The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and…
Insmed’s treatment-resistant lung disease drug gets FDA approval
(Reuters) – The U.S. Food and Drug Administration on Friday approved Insmed Inc’s lead drug to treat a rare, chronic…
Drug shortages may add $230 million to annual U.S. drug costs
(Reuters Health) – Prescription drug shortages may drive up prices twice as much as they would rise with medicines in…
Diabetes drugs less affordable, less available in lower income countries
(Reuters Health) – People who live in low-income and middle-income countries may have a harder time finding and affording essential…
China sacks six senior officials at food and drug regulator over vaccine scandal
SHANGHAI (Reuters) – China said on Saturday it has sacked six senior officials at its food and drug regulator after…
China to add more cancer drugs to reimbursement list, talks end in Sept: Xinhua
SHANGHAI (Reuters) – China plans to add a range of cancer drugs to medicines eligible for reimbursement from the government,…
Allergan sues Pfizer over costs of opioid litigation
(Reuters) – Allergan Plc (AGN.N) on Thursday sued Pfizer Inc (PFE.N) to force its larger rival to cover any damages…
FDA declines to approve Insys Therapeutic’s opioid painkiller
(Reuters) – Insys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller,…
Trump eases car tariff threat as U.S., EU launch talks to quell trade tensions
WASHINGTON (Reuters) – In what the EU chief called a “major concession,” U.S. President Donald Trump agreed on Wednesday to…
Mersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on…
Pfizer-Lilly pain drug meets late-stage trial goals
(Reuters) – An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of…
Abbott Labs raises 2018 earnings forecast, shares hit record high
(Reuters) – Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand…
J&J vows to overturn $4.7 billion talc verdict but experts see hurdles
NEW YORK (Reuters) – Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who…
CTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the…
Missouri appeals court tosses $55 million J&J talc-powder verdict
(Reuters) – A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a…
U.S. medical device firm electroCore IPO price set at $15 per share
(Reuters) – U.S. medical device maker electroCore Llc’s initial public offering is expected to price at $15 per share, Chief…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they…
Soaring costs, loss of benefits top Americans’ healthcare worries: Reuters/Ipsos poll
(Reuters) – For over a year now, Americans have listed healthcare as the most important problem facing the country, according…
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) – A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to…
Leading oncology group wary of Trump drug price proposals
CHICAGO (Reuters) – America’s leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs,…
TherapeuticsMD’s therapy for menopause-related condition gets approval
(Reuters) – Women’s healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its…
EU makes it easier for companies to produce generic medicines for export
BRUSSELS (Reuters) – The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic…
U.S. jury fails to reach verdict in latest J&J talc trial
NEW YORK (Reuters) – A South Carolina jury on Friday could not agree on a verdict in a case of…
U.S. jury fails to reach verdict in latest J&J talc trial
NEW YORK (Reuters) – A South Carolina jury on Friday could not agree on a verdict in a case of…
FDA issues warning letters to companies selling kratom products
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it issued warning letters to three companies that illegally…
PM May challenges scientists to help transform Britain after Brexit
LONDON (Reuters) – Britain’s prime minister challenged scientists on Monday to help diagnose cancer earlier and create zero-emission cars, trying…
British PM May calls on health, tech sectors to work on cancer
LONDON (Reuters) – Prime Minister Theresa May will call on Britain’s health service, charities and artificial intelligence sector to work…
Evolus investors frown as FDA declines to approve Botox rival
(Reuters) – U.S. health regulators on Wednesday declined to approve Evolus Inc’s (EOLS.O) rival product to Allergan Plc’s (AGN.N) Botox,…
Evolus investors frown as FDA declines to approve Botox rival
(Reuters) – U.S. health regulators on Wednesday declined to approve Evolus Inc’s (EOLS.O) rival product to Allergan Plc’s (AGN.N) Botox,…
Novartis top lawyer exits in wake of Trump attorney deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2…
Novartis ditches lawyer as head rolls over Trump lawyer deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2…